Arthur G. Pratt

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Frances Humby, Patrick Durez, Maya H Buch et al. · The Lancet · 2021 · 315 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Therapeutic advances in rheumatoid arthritis

Philip M. Brown, Arthur G. Pratt, Kimme L Hyrich · BMJ · 2024 · 273 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort

Zhuo Chen, Andrew D. Paterson, John M. Lachin et al. · Proceedings of the National Academy of Sciences · 2016 · 240 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

BIRTHMARKS IN INFANTS

Arthur G. Pratt · Archives of Dermatology · 1953 · 235 citations

Medicine, Dermatology, Pediatrics +9